IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Chiara Cipollari, Valentina Chiminazzo et al.|Cancer|2024Cited by 8
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancerGaya Spolverato, Monica Ortenzi, Matteo Fassan et al.|British journal of surgery|2023Cited by 4
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancerGiulia Becherucci, Daunia Verdi, Cesare Ruffolo et al.|Surgery|2024Cited by 2
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesionsBeatrice Salmaso, Alessandra Piccioli, Melania Scarpa et al.|Scientific Reports|2024Cited by 0
Gut microbiota-associated predictors as biomarkers of neoadjuvant treatment response in rectal cancer-a systematic reviewAstghik Stepanyan, Licia Laurino, Andromachi Kotsafti et al.|British Journal of Cancer|2026Cited by 0